Daten zu BAY 43-9006 auf dem Annual Meeting of the American Society of Clinical Oncology (ASCO)

5. - 8. Juni 2004, New Orleans

Hintergrundinformationen (nur in Englisch verfügbar)
BAY 43-9006 Fact Sheet Download (PDF, 184 KB) sammeln
BAY 43-9006 Clinical Trial Overview Download (PDF, 59 KB) sammeln
Background Information on Renal Cell Cancer Download (PDF, 148 KB) sammeln
Background Information on Melanoma Download (PDF, 27 KB) sammeln
List of BAY 43-9006 Presentations at ASCO 2004 Download (PDF, 168 KB) sammeln
Glossary of Terms Download (PDF, 133 KB) sammeln

ASCO 2004 Abstracts and Oral Presentations on BAY 43-9006

Preliminary antitumor activity of BAY 43-9006 in metastatic renal cell carcinoma and other advanced refractory solid tumors in a phase II randomized discontinuation trial: Abstract No: 4501

Phase I/II trial of BAY 43-9006, carboplatin and paclitaxel demonstrates preliminary antitumor activity in the expansion cohort of patients with metastatic melanoma: Abstract No: 7507

A randomized phase I clinical and biologic study of two schedules of BAY 43-9006 in patients with myelodysplastic syndrome or acute myeloid leukemia: A National Cancer Institute of Cancer Clinical Trials Group Study: Abstract No: 6611

A phase I/II trial of BAY 43-9006 and gemcitabine in advanced solid tumors and in advanced pancreatic cancer: Abstract No: 3059

Results of a phase I trial of BAY 43-9006 in combination with doxorubicin in patients with refractory solid tumors: Abstract No: 3049

Novel methodology of response assessment in hepatocellular carcinoma – Assessing response by change in tumor enhancement in distinction from conventional means: Abstract No: 3107

Results of a phase I trial of BAY 43-9006 in combination with oxaliplatin in patients with refractory solid tumors: Abstract No: 3056

Pharmacodynamic study of the raf kinase inhibitor BAY 43-9006: Mechanisms of hypertension: Abstract No: 2035

BAY 43-9006 in patients with advanced melanoma: The Royal Marsden experience: Abstract No: 7506

ASCO Homepage: www.asco.org


Clinical trials information: www.clinicaltrials.gov


American Cancer Society: www.cancer.org


Information on renal cell cancer: www.kidneycancerassociation.org


Information on melanoma: www.melanomainternational.org

Letzte Änderung: 14. Januar 2014 Copyright © Bayer AG